Renalase regulates peripheral and central dopaminergic activities

Area of Science:

• Biochemistry
• Nephrology
• Pharmacology

Background:

• Renalase, an FAD/NADH-dependent amine oxidase, is primarily found in the kidney and circulates in blood and urine.
• It is hypothesized to metabolize catecholamines, playing a role in regulating their levels.

Purpose of the Study:

• To investigate the impact of renalase deficiency on central and peripheral dopaminergic activities.
• To assess the effects of recombinant renalase administration on catecholamine levels in a knockout mouse model.

Main Methods:

• Evaluation of catecholamine levels (epinephrine, norepinephrine, dopamine) in plasma and urine of renalase knockout (KO) and wild-type (WT) mice.
• Measurement of urinary dopamine-to-l-DOPA ratios and renal aromatic-l-amino acid decarboxylase (AADC) activity.
• Administration of recombinant renalase (RR) to KO mice and subsequent analysis of plasma/urine catecholamines, AADC activity, and LAT1 expression.

Main Results:

• Renalase KO mice exhibited elevated plasma and urinary levels of epinephrine, norepinephrine, and dopamine compared to WT mice.
• KO mice showed increased urinary dopamine-to-l-DOPA ratios without altered AADC activity; RR administration normalized these levels and increased AADC activity.
• Renalase deficiency led to increased LAT1 expression in the renal cortex, which was reversed by RR administration.

Conclusions:

• Renalase deficiency contributes to altered catecholamine metabolism and dopaminergic system activation in the kidney.
• Overexpression of LAT1 in renalase-deficient mice may enhance l-DOPA availability, activating the renal dopaminergic system.
• Recombinant renalase effectively modulates catecholamine levels and renal dopaminergic activity, highlighting its therapeutic potential.